Latest news with #TomGodfrey
Business Insider
21-05-2025
- Business
- Business Insider
Ord Minnett Sticks to Its Buy Rating for Monash IVF Group Ltd (MVF)
In a report released today, Tom Godfrey from Ord Minnett maintained a Buy rating on Monash IVF Group Ltd (MVF – Research Report), with a price target of A$1.05. The company's shares opened today at A$0.75. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter According to TipRanks, Godfrey is ranked #1853 out of 9519 analysts. In addition to Ord Minnett, Monash IVF Group Ltd also received a Buy from Macquarie's Rachael Harwood in a report issued today. However, yesterday, RBC Capital maintained a Hold rating on Monash IVF Group Ltd (ASX: MVF). The company has a one-year high of A$1.47 and a one-year low of A$0.68. Currently, Monash IVF Group Ltd has an average volume of 2.19M.
Business Insider
08-05-2025
- Business
- Business Insider
Ord Minnett Sticks to Their Buy Rating for 4DMedical Ltd (4DX)
Ord Minnett analyst Tom Godfrey maintained a Buy rating on 4DMedical Ltd (4DX – Research Report) today and set a price target of A$0.76. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. According to TipRanks, Godfrey is ranked #1741 out of 9472 analysts. Currently, the analyst consensus on 4DMedical Ltd is a Moderate Buy with an average price target of A$0.70. Based on 4DMedical Ltd's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$2.9 million and a GAAP net loss of A$19.17 million. In comparison, last year the company earned a revenue of A$792.51 thousand and had a GAAP net loss of A$15.61 million
